176 related articles for article (PubMed ID: 26608138)
1. Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.
Bell RB; Leidner R; Feng Z; Crittenden MR; Gough MJ; Fox BA
J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S107-15. PubMed ID: 26608138
[No Abstract] [Full Text] [Related]
2. Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma.
Sadeghi N; Black MJ; Hier MP; Shenouda G; Karp SE
Arch Otolaryngol Head Neck Surg; 1997 Jan; 123(1):25-30. PubMed ID: 9006500
[TBL] [Abstract][Full Text] [Related]
3. Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.
Rosewell Shaw A; Porter CE; Watanabe N; Tanoue K; Sikora A; Gottschalk S; Brenner MK; Suzuki M
Mol Ther; 2017 Nov; 25(11):2440-2451. PubMed ID: 28974431
[TBL] [Abstract][Full Text] [Related]
4. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
Strome SE; Dong H; Tamura H; Voss SG; Flies DB; Tamada K; Salomao D; Cheville J; Hirano F; Lin W; Kasperbauer JL; Ballman KV; Chen L
Cancer Res; 2003 Oct; 63(19):6501-5. PubMed ID: 14559843
[TBL] [Abstract][Full Text] [Related]
5. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
[TBL] [Abstract][Full Text] [Related]
6. Oral complications of experimental plasma exchange in head and neck cancer.
Jackson MJ; Seder RH; Katz AE
J Prosthet Dent; 1986 Jun; 55(6):718-22. PubMed ID: 3522867
[No Abstract] [Full Text] [Related]
7. A murine model for the immunotherapy of head and neck squamous cell carcinoma.
Hier MP; Black MJ; Shenouda G; Sadeghi N; Karp SE
Laryngoscope; 1995 Oct; 105(10):1077-80. PubMed ID: 7564839
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of head and neck cancer.
Resser JR; Carbone DP
Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice.
Chikamatsu K; Reichert TE; Kashii Y; Saito T; Kawashiri S; Yamamoto E; Whiteside TL
Int J Cancer; 1999 Aug; 82(4):532-7. PubMed ID: 10404067
[TBL] [Abstract][Full Text] [Related]
10. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B
Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201
[TBL] [Abstract][Full Text] [Related]
11. Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.
Hoffmann TK; Bier H; Whiteside TL
Cancer Immunol Immunother; 2004 Dec; 53(12):1055-67. PubMed ID: 15095020
[TBL] [Abstract][Full Text] [Related]
12. A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.
Saito H; Ando S; Morishita N; Lee KM; Dator D; Dy D; Shigemura K; Adhim Z; Nibu K; Fujisawa M; Shirakawa T
Anticancer Res; 2014 Jul; 34(7):3365-70. PubMed ID: 24982341
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
14. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for head and neck squamous cell carcinoma.
Li Q; Prince ME; Moyer JS
Oral Oncol; 2015 Apr; 51(4):299-304. PubMed ID: 25624094
[TBL] [Abstract][Full Text] [Related]
17. [Future Prospects on neoplasm antigen vaccine therapy for patients with head and neck squamous cell carcinoma].
Eura M
Nihon Jibiinkoka Gakkai Kaiho; 2002 Mar; 105(3):201-7. PubMed ID: 12014346
[No Abstract] [Full Text] [Related]
18. Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study.
To WC; Wood BG; Krauss JC; Strome M; Esclamado RM; Lavertu P; Dasko D; Kim JA; Plautz GE; Leff BE; Smith V; Sandstrom-Wakeling K; Shu S
Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1225-31. PubMed ID: 11031409
[TBL] [Abstract][Full Text] [Related]
19. Vaccination Against Human Papilloma Viruses Leads to a Favorable Cytokine Profile of Specific T Cells.
Luckau S; Wehrs TP; Brandau S; Horn PA; Lindemann M
J Immunother; 2016 Oct; 39(8):316-20. PubMed ID: 27548034
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
Schoppy DW; Sunwoo JB
Hematol Oncol Clin North Am; 2015 Dec; 29(6):1033-43. PubMed ID: 26568546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
